Fat metabolism regulation everyday food choices have a major impact on health, by either increasing or decreasing the risk of disease, Fat metabolism regulation.
Lipids and fatty acids are well known regulatioj play an rwgulation part in metabolic regulation, metabooism the risk of cardiometabolic disease. However, there is a lack of mechanistic insights into their Fxt on lipid metabolism and metabolic Ac in gestational diabetes.
Interindividual metabllism in the response to environmental Fat blocker for athletes, including the diet, metabolic regulation and risk profiles is a focus area within the field of Fat burn community nutrition, aiming Holistic nutrition tips a personalized nutrition or precision nutrition approach to prevention and treatment regulatioh diet-related diseases.
Regulwtion succeed with precision nutrition, regulatoon more profound Ac in gestational diabetes of the metabolic regulstion mechanisms of lipids and fatty acids, including interindividual Fat metabolism regulation, is necessary to enhance metablism understanding of the development of cardiometabolic disease, and how mefabolism prevent it.
Ac in gestational diabetes Special Issue aims to include metavolism research and up-to-date reviews on metabo,ism regulation of lipids and fatty acids, in mehabolism to different risk profiles metabotypes of cardiometabolic disease.
Keywords: Metqbolism acids, Fat metabolism regulation, metabolic regulation, gut microbiota, gut microbiota metabolites, metabotypes, cardiometabolic disease. Individual response Regulatioh dietary fat, and the effect on lipid Fwt and cardiometabolic regulation.
Please find out more about Herbal weight loss regimen Ac in gestational diabetes and Ac in gestational diabetes policies, here.
Submission metavolism can reulation found hereand please submit metabolisj the series via Ac in gestational diabetes submission system there will be a field for which you can indicate if you are submitting to this series.
Non-high-density lipoprotein cholesterol non-HDL-C may be an independent risk factor for cardio-cerebrovascular disease CVD ; however, the cutoff level in patients on maintenance hemodialysis MHD is unknown.
Acylcarnitine is an intermediate product of fatty acid oxidation. It is reported metabklism be closely associated with the occurrence of diabetic cardiomyopathy DCM. However, the mechanism of acylcarnitine affecting Dyslipidemia is a feature of impaired metabolic health in conjunction with impaired glucose metabolism and central obesity.
However, the contribution of factors to postprandial lipemia in healthy but metabolic The mstabolism effect of maternal high-fat diet HFD on the fetal rat regulagion may cause later development of non-alcoholic fatty liver disease NAFLD.
The aim of this study was to evaluate the effect of mater Obesity and its complications constitute a substantial burden. Considerable published research describes the novel relationships between obesity and gut microbiota communities. It is becoming evident that micr Skip to main content. Search all BMC articles Search.
Keywords: Fatty acids, lipids, metabolic regulation, gut microbiota, gut microbiota metabolites, metabotypes, cardiometabolic disease Topics: Individual response to dietary fat, and the effect on lipid metabolism and cardiometabolic regulation Dietary fat and regulation of gut microbiota Individual gut microbiota signature, effect on lipid metabolism and cardiometabolic regulation Microbiota derived metabolites, lipid metabolism and cardiometabolic regulation Questions to be answered: What fegulation the individual differences in the response to fatty acids and lipids?
Do dietary fatty acids and lipids retulation the gut microbiota, and are there individual differences? How do short chain fatty acids SCFA affect metabolic regulation, including gene transcription? How do microbial lipids alter intestinal and circulating lipid concentrations, and thereby impact metabolic regulation of the host?
All submissions should be made by June 30th, Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis Non-high-density lipoprotein cholesterol non-HDL-C may be an independent risk factor for cardio-cerebrovascular disease CVD ; however, the cutoff level in patients on maintenance hemodialysis MHD is unknown.
Authors: Denggui Luo, Yueming Luo, Yanhong Zou, Yuanzhao Xu, Bo Fu, Dong Yang, Jun Yang, Cai Xu, Shuyi Ling, Shunmin Li and Airong Qi. Citation: Lipids in Health and Disease 20 Content type: Research Published on: 13 November Authors: Dan-meng Zheng, Zhen-ni An, Ming-hao Ge, Dong-zhuo Wei, Ding-wen Jiang, Xue-jiao Xing, Xiao-lei Shen and Chang Liu.
Content type: Research Metbaolism on: 2 November Authors: Stephanie M. Wilson, Adam P. Maes, Carl J. Yeoman, Seth T.
Walk and Mary P. Content type: Research Published on: 20 September Regultion Szu-Wei Huang, Yu-Che Ou, Kuo-Shu Tang, Hong-Ren Yu, Li-Tung Huang, You-Lin Tain, I-Chun Lin, Jiunn-Ming Sheen, Chih-Yao Hou, Ching-Chou Tsai FFat Mao-Meng Tiao.
Content type: Research Published on: 8 September Authors: A. Cunningham, J. Stephens and D. Content type: Review Published on: 7 July
: Fat metabolism regulation| Fatty acid metabolism - Wikipedia | Gatta, A. AM Fat metabolism regulation Metabbolism Endocrinol Metab. Wang, D. Perilipin, a Diabetic retinopathy management hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. CAS PubMed Google Scholar Nutting, D. Sugar acids. S68—S84, 85— |
| 1. Obesity: an overview | Subsequently, regullation receptor was cloned in the human [ 55 Antibacterial hair products Fat metabolism regulation well as in rodents regulatioon 56 Ac in gestational diabetes and was metaboliwm PPARδ. Curr Biol 22, — Adv Exp Med Biol. Article CAS Google Scholar Cheema SK, Agellon LB: The murine and human cholesterol 7 α-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor α. Clin Lipidol 5, — |
| Regulation of intestinal lipid metabolism: current concepts and relevance to disease | CAS PubMed Google Scholar Mansbach, C. CAS PubMed PubMed Central Google Scholar Kassan, A. elegans fat 2. Forsythe M. FFA exert dual effects on insulin secretion, dependent on the duration of exposure. |
Fat metabolism regulation -
The free fatty acids released by the digestion of the chylomicrons are absorbed by the adipocytes [ citation needed ] , where they are resynthesized into triglycerides using glycerol derived from glucose in the glycolytic pathway [ citation needed ].
These triglycerides are stored, until needed for the fuel requirements of other tissues, in the fat droplet of the adipocyte. The liver absorbs a proportion of the glucose from the blood in the portal vein coming from the intestines. After the liver has replenished its glycogen stores which amount to only about g of glycogen when full much of the rest of the glucose is converted into fatty acids as described below.
These fatty acids are combined with glycerol to form triglycerides which are packaged into droplets very similar to chylomicrons, but known as very low-density lipoproteins VLDL.
These VLDL droplets are processed in exactly the same manner as chylomicrons, except that the VLDL remnant is known as an intermediate-density lipoprotein IDL , which is capable of scavenging cholesterol from the blood.
This converts IDL into low-density lipoprotein LDL , which is taken up by cells that require cholesterol for incorporation into their cell membranes or for synthetic purposes e. the formation of the steroid hormones.
The remainder of the LDLs is removed by the liver. Adipose tissue and lactating mammary glands also take up glucose from the blood for conversion into triglycerides.
This occurs in the same way as in the liver, except that these tissues do not release the triglycerides thus produced as VLDL into the blood.
All cells in the body need to manufacture and maintain their membranes and the membranes of their organelles. Whether they rely entirely on free fatty acids absorbed from the blood, or are able to synthesize their own fatty acids from blood glucose, is not known.
The cells of the central nervous system will almost certainly have the capability of manufacturing their own fatty acids, as these molecules cannot reach them through the blood brain barrier.
Much like beta-oxidation , straight-chain fatty acid synthesis occurs via the six recurring reactions shown below, until the carbon palmitic acid is produced. The diagrams presented show how fatty acids are synthesized in microorganisms and list the enzymes found in Escherichia coli.
FASII is present in prokaryotes , plants, fungi, and parasites, as well as in mitochondria. In animals as well as some fungi such as yeast, these same reactions occur on fatty acid synthase I FASI , a large dimeric protein that has all of the enzymatic activities required to create a fatty acid.
FASI is less efficient than FASII; however, it allows for the formation of more molecules, including "medium-chain" fatty acids via early chain termination. by transferring fatty acids between an acyl acceptor and donor.
They also have the task of synthesizing bioactive lipids as well as their precursor molecules. Elongation, starting with stearate , is performed mainly in the endoplasmic reticulum by several membrane-bound enzymes.
The enzymatic steps involved in the elongation process are principally the same as those carried out by fatty acid synthesis , but the four principal successive steps of the elongation are performed by individual proteins, which may be physically associated.
Abbreviations: ACP — Acyl carrier protein , CoA — Coenzyme A , NADP — Nicotinamide adenine dinucleotide phosphate. Note that during fatty synthesis the reducing agent is NADPH , whereas NAD is the oxidizing agent in beta-oxidation the breakdown of fatty acids to acetyl-CoA. This difference exemplifies a general principle that NADPH is consumed during biosynthetic reactions, whereas NADH is generated in energy-yielding reactions.
The source of the NADPH is two-fold. NADPH is also formed by the pentose phosphate pathway which converts glucose into ribose, which can be used in synthesis of nucleotides and nucleic acids , or it can be catabolized to pyruvate.
In humans, fatty acids are formed from carbohydrates predominantly in the liver and adipose tissue , as well as in the mammary glands during lactation. The pyruvate produced by glycolysis is an important intermediary in the conversion of carbohydrates into fatty acids and cholesterol.
However, this acetyl CoA needs to be transported into cytosol where the synthesis of fatty acids and cholesterol occurs. This cannot occur directly. To obtain cytosolic acetyl-CoA, citrate produced by the condensation of acetyl CoA with oxaloacetate is removed from the citric acid cycle and carried across the inner mitochondrial membrane into the cytosol.
The oxaloacetate is returned to mitochondrion as malate and then converted back into oxaloacetate to transfer more acetyl-CoA out of the mitochondrion.
Acetyl-CoA is formed into malonyl-CoA by acetyl-CoA carboxylase , at which point malonyl-CoA is destined to feed into the fatty acid synthesis pathway. Acetyl-CoA carboxylase is the point of regulation in saturated straight-chain fatty acid synthesis, and is subject to both phosphorylation and allosteric regulation.
Regulation by phosphorylation occurs mostly in mammals, while allosteric regulation occurs in most organisms. Allosteric control occurs as feedback inhibition by palmitoyl-CoA and activation by citrate.
When there are high levels of palmitoyl-CoA, the final product of saturated fatty acid synthesis, it allosterically inactivates acetyl-CoA carboxylase to prevent a build-up of fatty acids in cells.
Citrate acts to activate acetyl-CoA carboxylase under high levels, because high levels indicate that there is enough acetyl-CoA to feed into the Krebs cycle and produce energy. High plasma levels of insulin in the blood plasma e. after meals cause the dephosphorylation and activation of acetyl-CoA carboxylase, thus promoting the formation of malonyl-CoA from acetyl-CoA, and consequently the conversion of carbohydrates into fatty acids, while epinephrine and glucagon released into the blood during starvation and exercise cause the phosphorylation of this enzyme, inhibiting lipogenesis in favor of fatty acid oxidation via beta-oxidation.
Disorders of fatty acid metabolism can be described in terms of, for example, hypertriglyceridemia too high level of triglycerides , or other types of hyperlipidemia. These may be familial or acquired.
Familial types of disorders of fatty acid metabolism are generally classified as inborn errors of lipid metabolism. These disorders may be described as fatty acid oxidation disorders or as a lipid storage disorders , and are any one of several inborn errors of metabolism that result from enzyme or transport protein defects affecting the ability of the body to oxidize fatty acids in order to produce energy within muscles, liver, and other cell types.
When a fatty acid oxidation disorder affects the muscles, it is a metabolic myopathy. Moreover, cancer cells can display irregular fatty acid metabolism with regard to both fatty acid synthesis [44] and mitochondrial fatty acid oxidation FAO [45] that are involved in diverse aspects of tumorigenesis and cell growth.
Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools. What links here Related changes Upload file Special pages Permanent link Page information Cite this page Get shortened URL Download QR code Wikidata item.
Download as PDF Printable version. Set of biological processes. Main article: Fatty acid synthesis. Main article: Citric acid cycle § Glycolytic end products are used in the conversion of carbohydrates into fatty acids. In: Biochemistry Fourth ed.
New York: W. Freeman and Company. ISBN doi : PMID S2CID Pflügers Archiv: European Journal of Physiology. Molecular Aspects of Medicine. PMC Jul J Neurosci. Feb J Cereb Blood Flow Metab. Biochemistry Fourth ed.
Donald; Stafstrom, Carl E. ISSN Molecular Genetics and Metabolism. W; Koeslag, J. European Journal of Applied Physiology. Toxicol Appl Pharmacol. Invited review. Nigerian Journal of Physiological Science.
Archived from the original on 26 September Retrieved 7 August Applications" PDF. Biotechnology and Bioengineering.
Ann NY Acad Sci. Bibcode : NYASA. Vander Jagt; B. Robinson; K. Taylor; L. Hunsaker Aldose reductase, methylglyoxal, and diabetic complications". The Journal of Biological Chemistry. An introduction to behavioral endocrinology 3rd ed.
Sunderland, Mass: Sinauer Associates. The solvent properties of dilute micellar solutions of conjugated bile salts". Gropper, Jack L. Advanced nutrition and human metabolism 6th ed.
In: Gray's Anatomy Thirty-seventh ed. Edinburgh: Churchill Livingstone. European Journal of Biochemistry. Hamilton, and Wolf Hamm. Oxford: Blackwell Pub.
MetaCyc Metabolic Pathway Database. In American Oil Chemists' Society ed. AOCS Lipid Library. Archived from the original on Retrieved Progress in Lipid Research. Foufelle Hormone Research.
Voet; Charlotte W. Pratt Fundamentals of Biochemistry, 2nd Edition. John Wiley and Sons, Inc. Life Sciences. Journal of Physiology and Biochemistry.
Inborn error of lipid metabolism : fatty-acid metabolism disorders. Biotinidase deficiency BTD. Carnitine CPT1 CPT2 CDSP CACTD Adrenoleukodystrophy ALD.
Acyl CoA dehydrogenase Short-chain SCADD Medium-chain MCADD Long-chain 3-hydroxy LCHAD Very long-chain VLCADD Mitochondrial trifunctional protein deficiency MTPD : Acute fatty liver of pregnancy.
Propionic acidemia PCC deficiency. Malonic aciduria MCD. Sjögren—Larsson syndrome SLS. Metabolism , catabolism , anabolism. Metabolic pathway Metabolic network Primary nutritional groups. Purine metabolism Nucleotide salvage Pyrimidine metabolism Purine nucleotide cycle.
Pentose phosphate pathway Fructolysis Polyol pathway Galactolysis Leloir pathway. Glycosylation N-linked O-linked. Photosynthesis Anoxygenic photosynthesis Chemosynthesis Carbon fixation DeLey-Doudoroff pathway Entner-Doudoroff pathway.
Xylose metabolism Radiotrophism. Fatty acid degradation Beta oxidation Fatty acid synthesis. Steroid metabolism Sphingolipid metabolism Eicosanoid metabolism Ketosis Reverse cholesterol transport.
Metal metabolism Iron metabolism Ethanol metabolism Phospagen system ATP-PCr. Metabolism map. Carbon fixation. Photo- respiration. Pentose phosphate pathway. Citric acid cycle. Glyoxylate cycle. Urea cycle. Fatty acid synthesis. Fatty acid elongation. Beta oxidation.
beta oxidation. Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine.
de Wit, N. BMC Med. Genomics 1 , 14 Kondo, H. Hayashi, H. Fat feeding increases size, but not number, of chylomicrons produced by small intestine.
Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes. Cell 15 , — Atzel, A. Identification of two classes of lipid molecule binding sites on the microsomal triglyceride transfer protein. Biochemistry 33 , — Gordon, D. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step.
Mechanism of microsomal triglyceride transfer protein catalyzed lipid transport. Biochemistry 32 , — Amino acids in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.
Jiang, Z. Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system. Xie, Y. Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency.
Wetterau, J. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Ricci, B. A amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia.
Muller, D. Vitamin E and neurological function. Food Res. Runge, P. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.
Long-term management of abetalipoproteinaemia. Possible role for vitamin E. Hooper, A. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
Schonfeld, G. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol. Life Sci. Lehner, R. Lumenal lipid metabolism: implications for lipoprotein assembly. Yang, L. Apparent convergence at 2-monoacylglycerol level of phosphatidic acid and 2-monoacylglycerol pathways of synthesis of chylomicron triacylglycerols.
Halpern, J. Nutting, D. Care 2 , — Lu, S. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size. Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.
Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride? Black, D. Development and physiological regulation of intestinal lipid absorption. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion. Ostos, M. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice.
Qin, X. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Vowinkel, T. Apolipoprotein A-IV inhibits experimental colitis. Fujimoto, K. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation.
Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. Lo, C. Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake. Endocrinology , — Li, X.
ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt signaling. Wang, F. Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion.
Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. Xu, X. Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis. Wong, W. Apolipoprotein AIV gene variant S is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels.
Kronenberg, F. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. Rao, R. Circulating apolipoprotein A-IV presurgical levels are associated with improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery.
Mansbach, C. Intracellular movement of triacylglycerols in the intestine. A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. Vesicle-associated membrane protein 7 is expressed in intestinal ER. Sane, A.
Understanding chylomicron retention disease through Sar1b Gtpase gene disruption: insight from cell culture. Charcosset, M. Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Sec24C is required for docking the prechylomicron transport vesicle with the Golgi.
The identification of a novel endoplasmic reticulum to Golgi SNARE complex used by the prechylomicron transport vesicle. Katz, L. Genetic and morphological analyses reveal a critical interaction between the C-termini of two SNARE proteins and a parallel four helical arrangement for the exocytic SNARE complex.
EMBO J. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. Berriot-Varoqueaux, N. Levy, E. Chylomicron retention disease: genetics, biochemistry, and clinical spectrum.
Effect of hydrophobic surfactant Pluronic L on lymphatic lipid transport in the rat. Kvietys, P. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Jattan, J. Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.
Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph. Windler, E. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. Pluronic L a potent inhibitor of the transport of intestinal chylomicrons. Ockner, R.
Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. Mahley, R. Lipoproteins associated with the Golgi apparatus isolated from epithelial cells of rat small intestine. Further studies on the mechanism of inhibition of intestinal chylomicron transport by Pluronic L Glickman, R.
The intestine as a source of apolipoprotein A1. USA 74 , — Jonas, A. Lecithin cholesterol acyltransferase. Connelly, M. SR-BI and HDL cholesteryl ester metabolism. Brunham, L. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
Iqbal, J. Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs.
Rashid, S. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.
Patsch, J. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. USA 75 , — Lipid absorption defects in intestine-specific microsomal triglyceride transfer protein and ATP-binding cassette transporter A1-deficient mice. Zhu, J.
A dynamic, cytoplasmic triacylglycerol pool in enterocytes revealed by ex vivo and in vivo coherent anti-stokes Raman scattering imaging. Kassan, A. Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains. Wilfling, F. Lipid droplet biogenesis.
Hung, Y. Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat.
Characterization of the proteome of cytoplasmic lipid droplets in mouse enterocytes after a dietary fat challenge. PLOS ONE 10 , e Lee, B. Differential association of adipophilin and TIP47 proteins with cytoplasmic lipid droplets in mouse enterocytes during dietary fat absorption.
Itabe, H. Perilipins: a diversity of intracellular lipid droplet proteins. Lipids Health Dis. Bouchoux, J. Cell , — Frank, D. Perilipin-2 modulates lipid absorption and microbiome responses in the mouse intestine.
Beilstein, F. Characteristics and functions of lipid droplets and associated proteins in enterocytes. Cell Res. Obrowsky, S. Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARα signaling.
Khaldoun, S. Autophagosomes contribute to intracellular lipid distribution in enterocytes. Cell 25 , — Du, H. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span.
Porto, A. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and cholesteryl ester storage diseases. Soayfane, Z. Exposure to dietary lipid leads to rapid production of cytosolic lipid droplets near the brush border membrane.
Accioly, M. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells.
Cancer Res. Moreira, L. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Metabolism of apical versus basolateral snmonoacylglycerol and fatty acids in rodent small intestine.
Uptake and metabolism of circulating fatty acids by rat intestine. Lagakos, W. Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis. Thomson, A. Dietary fat selectively alters transport properties of rat jejunum.
Sukhotnik, I. Effect of a high fat diet on lipid absorption and fatty acid transport in a rat model of short bowel syndrome. Uchida, A. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, alters triglyceride metabolism in enterocytes of mice.
Berger, J. Physiological and therapeutic roles of peroxisome proliferator-activated receptors. Diabetes Technol. Mochizuki, K. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
Karimian Azari, E. Possible role of intestinal fatty acid oxidation in the eating-inhibitory effect of the PPAR-α agonist Wy in high-fat diet fed rats. PLOS ONE 8 , e Hooper, L. Commensal host-bacterial relationships in the gut. El Aidy, S. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation.
Gut 62 , — Donaldson, G. Gut biogeography of the bacterial microbiota. Backhed, F. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Rabot, S. FASEB J. Martinez-Guryn, K. Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids.
Cell Host Microbe 23 , — e5 Sato, H. Antibiotics suppress activation of intestinal mucosal mast cells and reduce dietary lipid absorption in sprague-dawley rats.
Ji, Y. Activation of rat intestinal mucosal mast cells by fat absorption. Scudamore, C. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Heck, A. Orlistat, a new lipase inhibitor for the management of obesity.
Pharmacotherapy 20 , — Hofmann, A. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.
Gastroenterology 62 , — Parkinson, T. Effects of colestipol U,A , a new bile acid sequestrant, on serum lipids in experimental animals and man. Atherosclerosis 11 , — Bilheimer, D. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
USA 80 , — Davidson, M. Colesevelam hydrochloride cholestagel : a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Okuma, C. JTP, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.
Dow, R. Discovery of PF, a potent, selective, and orally bioavailable inhibitor of DGAT ACS Med. Defining the key pharmacophore elements of PF discovery of a potent, orally-active, neutral DGAT-1 inhibitor. Rizzo, M. Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
IDrugs 13 , — Aggarwal, D. JTT, a microsomal triglyceride transfer protein MTP inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.
BMC Cardiovasc. Hata, T. JTT, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Download references. The authors are grateful for the support of National Institutes of Health Grants DK , DK , and DK P. and HD D. The editorial assistance of A. Preston is greatly appreciated.
Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA. You can also search for this author in PubMed Google Scholar. and D. researched data for the article. Correspondence to Patrick Tso.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Lewis, M. Hussain and the other, anonymous, reviewer for their contribution to the peer review of this work. Reprints and permissions. Ko, CW. Regulation of intestinal lipid metabolism: current concepts and relevance to disease.
Nat Rev Gastroenterol Hepatol 17 , — Download citation. Accepted : 02 December Published : 03 February Issue Date : March Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Clinical and Experimental Medicine Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
Skip to main content Thank you for visiting nature. Subjects Lipids Small intestine. Abstract Lipids entering the gastrointestinal tract include dietary lipids triacylglycerols, cholesteryl esters and phospholipids and endogenous lipids from bile phospholipids and cholesterol and from shed intestinal epithelial cells enterocytes.
Key points Dietary lipids are digested and are taken up by enterocytes for re-esterification and packaging into pre-chylomicrons in the endoplasmic reticulum, trafficked to the Golgi and then secreted for transport in the lymphatic system.
Access through your institution. Buy or subscribe. Change institution. Learn more. References Kohan, A. CAS PubMed PubMed Central Google Scholar Tso, P. CAS PubMed PubMed Central Google Scholar Xiao, C.
CAS PubMed Google Scholar Hussain, M. CAS PubMed PubMed Central Google Scholar Welty, F. CAS PubMed PubMed Central Google Scholar Ferreira, H.
PubMed Google Scholar Shiau, Y. CAS PubMed Google Scholar Bernback, S. CAS PubMed Google Scholar Hamosh, M. CAS PubMed Google Scholar Watkins, J.
CAS PubMed Google Scholar Phan, C. CAS PubMed Google Scholar Einarsson, K. PubMed Google Scholar Chow, S. CAS PubMed Google Scholar Lobo, M. CAS PubMed Google Scholar Lynes, M. CAS PubMed PubMed Central Google Scholar Nassir, F.
CAS PubMed Google Scholar Drover, V. CAS PubMed PubMed Central Google Scholar Nauli, A. CAS PubMed PubMed Central Google Scholar Stahl, A. CAS PubMed Google Scholar Milger, K. CAS PubMed Google Scholar Gimeno, R. CAS PubMed Google Scholar Moulson, C. CAS PubMed Google Scholar Herrmann, T.
CAS PubMed PubMed Central Google Scholar Moulson, C. CAS PubMed Google Scholar Shim, J. CAS PubMed PubMed Central Google Scholar Niot, I. CAS PubMed Google Scholar Siddiqi, S.
CAS PubMed PubMed Central Google Scholar Thumser, A. CAS PubMed Google Scholar Hsu, K. CAS PubMed Google Scholar Corsico, B. CAS PubMed Google Scholar Storch, J.
CAS PubMed Google Scholar Van Heek, M. PubMed Google Scholar Sylven, C. CAS PubMed Google Scholar Turley, S. CAS PubMed Google Scholar Altmann, S.
CAS PubMed Google Scholar Jia, L. CAS PubMed PubMed Central Google Scholar Wang, L. CAS PubMed Google Scholar Geach, T. PubMed Google Scholar Myocardial Infarction Genetics Consortium Investigators, et al.
Google Scholar Kern, F. PubMed Google Scholar Li, P. PubMed Google Scholar Nihei, W. CAS PubMed PubMed Central Google Scholar Ge, L. CAS PubMed Google Scholar Ge, L. CAS PubMed Google Scholar Johnson, T.
CAS PubMed PubMed Central Google Scholar Bietrix, F. CAS PubMed PubMed Central Google Scholar Mardones, P. CAS PubMed Google Scholar Hayashi, A. CAS PubMed Google Scholar Lino, M.
CAS PubMed Google Scholar Morel, E. CAS PubMed Google Scholar Reboul, E. CAS PubMed Google Scholar During, A. CAS PubMed Google Scholar Borel, P.
CAS PubMed Google Scholar Weingartner, O. PubMed Google Scholar Berge, K. CAS PubMed Google Scholar Lutjohann, D. CAS PubMed Google Scholar Bjorkhem, I. CAS PubMed Google Scholar Bhattacharyya, A. CAS PubMed PubMed Central Google Scholar Miettinen, T. CAS PubMed Google Scholar Hu, M. CAS PubMed Google Scholar Plosch, T.
PubMed Google Scholar Yu, L. CAS PubMed Google Scholar Wang, J. CAS PubMed PubMed Central Google Scholar Temel, R. CAS PubMed PubMed Central Google Scholar Jakulj, L.
CAS PubMed Google Scholar van der Veen, J. PubMed PubMed Central Google Scholar Kruit, J. CAS PubMed Google Scholar de Boer, J. PubMed Google Scholar Vrins, C. CAS PubMed PubMed Central Google Scholar Siddiqi, S. CAS PubMed PubMed Central Google Scholar Kayden, H. CAS PubMed PubMed Central Google Scholar Babayan, V.
CAS PubMed Google Scholar Yen, C. CAS PubMed Google Scholar Cheng, D. CAS PubMed Google Scholar Yue, Y. CAS PubMed Google Scholar Nelson, D. CAS PubMed Google Scholar Gao, Y. CAS PubMed Google Scholar Hall, A. CAS PubMed Google Scholar Cao, J.
CAS PubMed Google Scholar Brandt, C. CAS PubMed Google Scholar Smith, S. CAS PubMed Google Scholar Chen, H.
CAS PubMed Google Scholar Stone, S. CAS PubMed Google Scholar van Rijn, J. PubMed Google Scholar Haas, J. CAS PubMed Google Scholar Dawson, P. CAS PubMed Google Scholar Nguyen, T. CAS PubMed Google Scholar Lee, O.
CAS PubMed Google Scholar Meiner, V. CAS PubMed Google Scholar Anderson, R. CAS PubMed Google Scholar Cases, S. CAS PubMed Google Scholar Buhman, K. CAS PubMed Google Scholar Repa, J. PubMed Google Scholar Rong, X. PubMed Central Google Scholar Li, Z. CAS PubMed PubMed Central Google Scholar Kabir, I.
CAS PubMed PubMed Central Google Scholar Demignot, S. CAS PubMed Google Scholar Sabesin, S. CAS PubMed Google Scholar de Wit, N. PubMed PubMed Central Google Scholar Kondo, H. CAS PubMed Google Scholar Hayashi, H. CAS PubMed PubMed Central Google Scholar Atzel, A.
Fat metabolism regulation acid metabolism consists metaboilsm various Ketosis Diet Plan processes involving or regulaation Ac in gestational diabetes to fatty acids Ft, a family of Regultaion classified within the lipid metabooism category. Regupation processes regualtion mainly Fat metabolism regulation divided into 1 regulatioh processes that OMAD weight loss results energy regulatin 2 anabolic processes where Fat metabolism regulation serve as building blocks for other compounds. In catabolism, fatty acids are metabolized to produce energy, mainly in the form of adenosine triphosphate ATP. When compared to other macronutrient classes carbohydrates and proteinfatty acids yield the most ATP on an energy per gram basis, when they are completely oxidized to CO 2 and water by beta oxidation and the citric acid cycle. In anabolism, intact fatty acids are important precursors to triglycerides, phospholipids, second messengers, hormones and ketone bodies. For example, phospholipids form the phospholipid bilayers out of which all the membranes of the cell are constructed from fatty acids. Phospholipids comprise the plasma membrane and other membranes that enclose all the organelles within the cells, such as the nucleusthe mitochondriaendoplasmic reticulumand the Golgi apparatus.
Video
Metabolism - Mobilization of TriglyceridesFat metabolism regulation -
Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall AR, Fruchart JC, Staels B, Lagrost L, Luc G: Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. Miller CW, Ntambi JM: Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.
Latruffe N, Nicolas-Frances V, Dasari VK, Osumi T: Studies on regulation of the peroxisomal beta-oxidation at the 3-ketothiolase step. Dissection of the rat liver thiolase B gene promoter.
Adv Exp Med Biol. Hertz R, Seckbach M, Zakin MM, Bar-Tana J: Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators.
Download references. Research by the authors' group is supported by the Canadian Institutes for Health Research and the Canadian Diabetes Association. CBC holds a Levesque Research Chair in Nutrisciences and Health at the University of Prince Edward Island.
The authors thank MB Wheeler and MC Saleh for reading the manuscript and for their helpful comments. Department of Biomedical Sciences, University of Prince Edward Island, University Avenue, Charlottetown, PE, C1A 4P3, Canada.
You can also search for this author in PubMed Google Scholar. Correspondence to Catherine B Chan. Reprints and permissions. Fatehi-Hassanabad, Z. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic β-cell function.
Nutr Metab Lond 2 , 1 Download citation. Received : 20 October Accepted : 05 January Published : 05 January Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative. Skip to main content. Search all BMC articles Search. Download PDF. Download ePub. Abstract Background Optimal pancreatic β-cell function is essential for the regulation of glucose homeostasis in both humans and animals and its impairment leads to the development of diabetes.
Results Free fatty acids represent an important factor linking excess fat mass to type 2 diabetes. Conclusion The role of the PPARs and SREBP-1c as potential mediators of lipotoxicity is an emerging area of interest. Introduction Fatty acids are physiologically important both structurally, as components of phospholipids and glycolipids, as well as functionally, as fuel molecules.
Figure 1. Full size image. Metabolism of fatty acids in the beta cell and insulin secretion Fatty acids, not glucose, are the major endogenous energy source for unstimulated islets [ 10 ].
Transcriptional regulation of free fatty acid metabolism Free fatty acid metabolism responds to varying metabolic states partially by induction of enzymes that promote either catabolic or anabolic processes.
Peroxisome proliferator-activated receptors The PPARs form a subfamily in the nuclear receptor superfamily. PPARα PPARα was the first member of this nuclear receptor subclass to be described. Figure 2.
Table 1 Selected hepatic PPARα regulated genes with at least one functional peroxisome proliferator receptor element PPRE identified within the promoter sequence Full size table. Peroxisome proliferator-activated receptors and β-cell function Both PPARα and PPARγ have been detected in pancreatic β-cells [ 76 , 77 ].
Sterol regulatory element binding protein The family of SREBPs governs transcriptional activation of a large number of genes involved in regulation of lipid metabolism, including lipogenesis, cholesterol transport and synthesis [ ]. Conclusions FFA exert dual effects on insulin secretion, dependent on the duration of exposure.
References Kutchai HC: Digestion and absorption. Google Scholar Oxidation of fatty acids. Google Scholar Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic.
Article CAS Google Scholar Centers for Disease Control and Prevention: National Diabetes Fact Sheet: National estimate and general information on diabetes in the United States, Article CAS Google Scholar Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from to results from the San Antonio Heart Study.
Article CAS Google Scholar Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Article CAS Google Scholar Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM: Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
Article CAS Google Scholar McGarry JD: What if Minkowski had been ageusic? Article CAS Google Scholar Malaisse WJ, Best L, Kawazu S, Malaisse-Lagae F, Sener A: The stimulus-secretion coupling of glucose-induced insulin release: fuel metabolism in islet deprived of exogenous nutrient.
Article CAS Google Scholar Hellerstrom C: Effects of carbohydrates on the oxygen consumption of isolated pancreatic islets of mice. Article CAS Google Scholar Vara E, Tamarit-Rodriguez J: Glucose stimulation of insulin secretion in islets of fed and starved rats and its dependence on lipid metabolism.
Article CAS Google Scholar Malaisse WJ: Insulin secretion: Multifactorial regulation for a single process of release. Article CAS Google Scholar Carpinelli AR, Curi R, Malaisse WJ: Long-term regulation of pancreatic B-cell responsiveness to D-glucose by food availability, feeding schedule and diet composition.
Article CAS Google Scholar Newgard CB, McGarry JD: Metabolic coupling factors in pancreatic β cell signal transduction. Article CAS Google Scholar Warnotte C, Gilon P, Nenquin M, Henquin JC: Mechanisms of the stimulation of insulin release by saturated fatty acids: a study of palmitate effects in mouse β-cells.
Article CAS Google Scholar Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD: Essentially of circulating fatty acids for glucose-stimulated insulin secretion in fasted rats.
Article CAS Google Scholar McGarry JD, Dobbins RL: Fatty acids, lipotoxicity and insulin secretion. Article CAS Google Scholar Hamilton JA, Civelek VN, Kamp F, Tornheim K, Corkey BE: Changes in internal pH caused by movement of fatty acids into and out of clonal pancreatic β-cells HIT.
CAS Google Scholar Matschinsky FM: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Article CAS Google Scholar McGarry JD: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
Article CAS Google Scholar Berne C: The metabolism of lipid in mouse pancreatic islets. Article CAS Google Scholar Boylan JG, Hamilton JA: Interactions of acyl-coenzyme A with phosphatidylcholine bilayers and serum albumin.
Article CAS Google Scholar Corkey B: Analysis of acyl-coenzyme A esters in biological samples. Article CAS Google Scholar Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, Lewis GF, Giacca A: Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.
Article CAS Google Scholar Unger RH: How obesity causes diabetes in Zucker diabetic fatty rats. Article Google Scholar Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF: Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. CAS Google Scholar Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF: Prolonged elevation of plasma free fatty acids impairs pancreatic B-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
Article CAS Google Scholar Kashyap SR, Belfort R, Berria R, Suraamornkul S, Pratipranawatr T, Finlayson J, Barrentine A, Bajaj M, Mandarino L, DeFronzo R, Cusi K: Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.
Article CAS Google Scholar Paolisso G, Gambardella A: Opposite effects of short and long-term fatty acid infusion on insulin secretion in healthy subjects.
Article CAS Google Scholar Stefan N, Fritsche A, Haring H, Stumvoll M: Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12 Ala polymorphism of the peroxisome proliferator-activated receptor γ2 gene.
Article CAS Google Scholar Paolisso G, Tagliamonte MR, Rizzo MR, Gualdiero P, Saccomanno F, Gambardella A, Giugliano D, D'Onofrio F, Howard BV: Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes.
Article CAS Google Scholar Qvigstad E, Mostad IL, Bjerve KS, Grill VE: Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects. Article CAS Google Scholar Unger RH: Lipotoxic diseases. Article CAS Google Scholar Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid induced β-cell apoptosis: a link between diabetes and obesity.
Article CAS Google Scholar Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.
Article CAS Google Scholar Kersten S: Effects of fatty acids on gene expression: role of peroxisome proliferator-activated receptor α, liver X receptor α and sterol regulatory element-binding protein-1 c.
Article CAS Google Scholar Reddy JK, Chu R: Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon. Article CAS Google Scholar Goldfischer SL: Peroxisomal diseases. CAS Google Scholar Rosen ED, Spiegelman BM: PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth.
Article CAS Google Scholar Sher T, Yi H-F, McBride OW, Gonzalez FJ: cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Article CAS Google Scholar Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator activated receptor PPARs : tissue distribution of PPAR-α, -β and -γ in the adult rat.
CAS Google Scholar Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor α in humans.
Article CAS Google Scholar Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages.
Article CAS Google Scholar Inoue I, Shino K, Noji S, Awata T, Katayama S: Expression of peroxisome proliferator-activated receptor α in primary cultures of human vascular endothelial cells.
Article CAS Google Scholar Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, Tedgui A: Activation of human aortic smooth-muscle cells is inhibited by PPARα but not PPARγ activators.
Article CAS Google Scholar Gottlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Article CAS Google Scholar Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators.
Article CAS Google Scholar Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W: Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Article CAS Google Scholar Kersten S: Peroxisome proliferator activated receptors and obesity.
Article CAS Google Scholar Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by some peroxisome proliferators.
Article CAS Google Scholar Cattley RC, DeLuca J, Elcombe C, Fenner-Crisp P, Lake BG, Marsman DS, Pastoor TA, Popp JA, Robinson DE, Schwetz B, Tugwood J, Wahli W: Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Article CAS Google Scholar Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism.
CAS Google Scholar Verges B: Clinical interest of PPAR ligands. Article CAS Google Scholar Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA: Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acid.
CAS Google Scholar Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
Article CAS Google Scholar Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B: Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.
Article CAS Google Scholar Bastie C, Holst D, Gaillard D, Jehl-Pietri C, Grimaldi PA: Expression of peroxisome proliferator-activated receptor PPARδ promotes induction of PPARγ and adipocyte differentiation in 3T3C2 fibroblasts. Article CAS Google Scholar Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV: Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.
Article CAS Google Scholar Gaw A, Packard CJ, Shepherd J: Fibrates. Article CAS Google Scholar Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L, Fishbein MC, Meehan WP, Hsueh WA: Expression and function of PPARγ in rat and human vascular smooth muscle cells.
Article CAS Google Scholar Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ: The nuclear receptor PPARγ and immunoregulation. Article CAS Google Scholar Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM: PPARγ is required for the differentiation of adipose tissue in vivo and in vitro.
Article CAS Google Scholar Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE: Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. Article CAS Google Scholar Tontonoz P, Hu E, Spiegelman BM: Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ.
Article CAS Google Scholar Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR α and PPAR γ activators.
Article CAS Google Scholar Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Article CAS Google Scholar Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Article CAS Google Scholar Walczak R, Tontonoz P: PPARadigms and PPARadoxes: expanding roles for PPAR γ in the control of lipid metabolism.
CAS Google Scholar Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin ob gene expression in 3T3-L1 adipocytes. Article CAS Google Scholar De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong KM, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ.
Article CAS Google Scholar Jiang C, Ting AT, Seed B: PPARγ agonists inhibit production of monocyte inflammatory cytokines. Article CAS Google Scholar Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP: Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
Article CAS Google Scholar Gimble JM, Pighetti GM, Lerner MR, Wu X, Lightfoot SA, Brackett DJ, Darcy K, Hollingsworth AB: Expression of peroxisome proliferator-activated receptor mRNA in normal and tumorigenic mammary glands.
Article CAS Google Scholar Zhou Y-T, Shimabukuro M, Wang M-Y, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH: Role of peroxisome proliferator-activated receptor α in disease of pancreatic β cells. Article CAS Google Scholar Dubois M, Paltou F, Kerr-Conte J, Gyr V, Vandewalle B, Desreumaux P, Auwerx J, Schoonjans K, Lefebvre J: Expression of peroxisome proliferator-activated receptor γ in normal human pancreatic islet cells.
Article CAS Google Scholar Shimomura K, Shimizu H, Ikeda M, Okada S, Kakei M, Matsumoto S, Mori M: Fenofibrate, troglitazone, and deoxy-Δ12, prostaglandin J2 close K ATP channels and induce insulin secretion. Article CAS Google Scholar Roduit R, Morin J, Masse F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M: Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-α gene in the pancreatic β-cell.
Article CAS Google Scholar Laybutt R, Hasenkamp W, Groff A, Grey S, Jonas JC, Kaneto H, Sharma A, Bonner-Weir S, Weir G: Beta-cell adaptation to hyperglycemia.
Article CAS Google Scholar Sugden MC, Bulmer K, Augustine D, Holness MJ: Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-α : implications for glucose-stimulated insulin secretion.
Article CAS Google Scholar Sugden MC, Holness MJ: Potential role of peroxisome proliferator-activated receptor-α in the modulation of glucose-stimulated insulin secretion.
Article CAS Google Scholar Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B: PPAR-α-null mice are protected from high-fat diet-induced insulin resistance. Article CAS Google Scholar Sugden MC, Bulmer K, Gibbons GF, Knight BL, Holness MJ: Peroxisome-proliferator-activated receptor-α PPARα deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Article CAS Google Scholar Kersten S, Mandard S, Escher P, Gonzalez FJ, Tafuri S, Desvergne B, Wahli W: The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.
Article CAS Google Scholar Maechler P, Wollheim CB: Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Article CAS Google Scholar Unger RH, Orci L: Lipoapoptosis: its mechanism and its diseases. Article CAS Google Scholar Prentki M, Joly E, El-Assaad W, Roduit R: Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity.
Article CAS Google Scholar Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, Semenkovich CF: PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells. CAS Google Scholar Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM, Reitman ML, Yakar S, Stannard B, Heron-Milhavet L, Wheeler MB, LeRoith D: Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
Article CAS Google Scholar Koh EH, Kim M-S, Park J-Y, Kim HS, Youn J-Y, Park H-S, Youn JH, Lee K-U: Peroxisome proliferator-activated receptor PPAR -α activation prevents diabetes in OLETF rats. Article CAS Google Scholar Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Molle DE: Peroxisome proliferator-acitvated receptors γ and α mediate in vivo regulation of uncoupling protein UCP-1, UCP-2, UCP-3 gene expression.
CAS Google Scholar Schrauwen P, Hesselink M: UCP2 and UCP3 in muscle controlling body metabolism. CAS Google Scholar Grav HJ, Tronstad KJ, Gudbrandsen OA, Berge K, Fladmark KE, Martinsen TC, Waldum H, Wergedahl H, Berge RK: Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 UCP-2 expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression.
Article CAS Google Scholar Chan CB, De Leo D, Joseph JW, McQuaid TS, Ha XF, Xu F, Tsushima RG, Pennefather PS, Salapatek AM, Wheeler MB: Increased uncoupling protein-2 levels in beta cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action.
Article CAS Google Scholar Hong Y, Fink BD, Dillon JS, Sivitz W: Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells. CAS Google Scholar Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB: Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction and type 2 diabetes.
Article CAS Google Scholar Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB, Wheeler MB: Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high fat diet.
Article CAS Google Scholar Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM: Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition.
Article CAS Google Scholar Shimabukuro M, Zhou Y-T, Lee Y, Unger RH: Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats.
Article CAS Google Scholar Sreenan S, Sturis J, Pugh W, Burant CF, Polonsky KS: Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. CAS Google Scholar Parton LE, Diraison F, Neill SE, Ghosh SK, Rubino MA, Bisi JE, Briscoe CP, Rutter GA: Impact of PPARγ overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays.
Article CAS Google Scholar Eto K, Yamashita T, Matsui J, Terauchi Y, Noda M, Kadowaki T: Genetic manipulation of fatty acid metabolism in β-cells are associated with dysregulated insulin secretion. Article CAS Google Scholar Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, Eto K, Tsubamoto Y, Okuno A, Murakami K, Sekihara H, Hasegawa G, Naito M, Toyoshima Y, Tanaka S, Shiota K, Kitamura T, Fujita T, Ezaki O, Aizawa S, Nagai R, Tobe K, Kimura S, Kadowaki T: PPAR-γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
Article CAS Google Scholar Kim HI, Cha JY, Kim SY, Kim JW, Roh KJ, Seong JK, Lee NT, Choi KY, Kim KS, Ahn YH: Peroxisomal proliferator-activated receptor-gamma upregulates glucokinase gene expression in beta-cells.
Article CAS Google Scholar Kim HI, Kim JW, Kim SH, Cha JY, Kim AS, Ahn YH: Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Article CAS Google Scholar Wang Z, Gleichmann H: Glut2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Article CAS Google Scholar Nakamichi Y, Kikuta T, Ito E, Ohara-Imaizumi M, Nishiwaki C, Ishida H, Nagamatsu S: PPAR-γ overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.
Article CAS Google Scholar Lupi R, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, Del Prato S: Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion.
Article CAS Google Scholar Diani AR, Sawada G, Wyse B, Marray FT, Khan M: Pioglitazone preserves pancreatic islet structure and insulin secretory funciton in three murine models of type 2 diabetes.
Article Google Scholar Higa M, Zhou Y-T, Ravazzola M, Baetens D, Orci L, Unger RH: Troglitazone prevents mitochondrial alterations, β cell destruction and diabetes in obese prediabetic rats.
Article CAS Google Scholar Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P: Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse.
Article CAS Google Scholar Pershadsingh HA: Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond diabetes: quo vadis?. Article CAS Google Scholar Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu C-H, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM: Targeted elimination of peroxisome proliferator-activated receptor γ in β cells leads to abnormalities in islet mass without compromising glucose homeostasis.
Article CAS Google Scholar Foufelle F, Ferre P: New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.
Article CAS Google Scholar Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
Article CAS Google Scholar Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger RH: Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets.
Article CAS Google Scholar Andreolas C, da Silva Xavier G, Diraison F, Zhao C, Varadi A, Lopez-Casillas F, Ferre P, Foufelle F, Rutter GA: Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in pancreatic MIN6 beta-cells.
Article CAS Google Scholar Wang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A, Wollheim CB: The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. Article CAS Google Scholar Diraison F, Parton L, Ferre P, Foufelle F, Briscoe CP, Leclerc I, Rutter GA: Over-expression of sterol-regulatory-element-binding protein-1c SREBP1c in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazolecarboxamide ribonucleoside AICAR.
Article CAS Google Scholar Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, Daniel KW, Collins S: Regulation of the uncoupling protein-2 gene in INS-1 β-cells by oleic acid. Article CAS Google Scholar Yamashita T, Eto K, Okazaki Y, Yamashita S, Yamauchi T, Sekine N, Nagai R, Noda M, Kadowaki T: Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a β-cell lipotoxicity model overexpressing sterol regulatory element binding protein-1c.
Article CAS Google Scholar Poitout V: β-cell lipotoxicity: burning fat into heat?. Article CAS Google Scholar Elholm M, Bjerking G, Knudsen J, Kristiansen K, Mandrup S: Regulatory elements in the promoter region of the rat gene encoding the acyl-CoA-binding protein.
Article CAS Google Scholar Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W: The PPARα-leukotriene B4 pathway to inflammation control. Article CAS Google Scholar Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK: Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
Article CAS Google Scholar Karam WG, Ghanayem BI: Induction of replication DNA synthesis and PPARα-dependent gene transcription by Wy in primary rat hepatocyte and non-parenchymal cell co-cultures.
Article CAS Google Scholar Berthou L, Duverger N, Emmanuel F, Langouet S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denefle P, Staels B, Branellec D: Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. Article CAS Google Scholar Raspe E, Madsen L, Lefebvre AM, Leitersdorf I, Gelman L, Peinado-Onsurbe J, Dallongeville J, Fruchart JC, Berge R, Staels B: Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid TTA via PPARα activation.
CAS Google Scholar Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B, Auwerx J: Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. Article CAS Google Scholar Prieur X, Coste H, Rodriguez JC: The human apolipoprotein AV gene is regulated by PPAR α and contains a novel FXR response element.
Article CAS Google Scholar Hertz R, Bishara-Shieban J, Bar-Tana J: Mode of action of peroxisome proliferators as hypolipidemic drugs. Article CAS Google Scholar Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting.
Article CAS Google Scholar Leone TC, Weinheimer CJ, Kelly DP: A critical role for the peroxisome proliferator-activated receptor α in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Article CAS Google Scholar Aoyama T, Peters JM, Iritani N, Nakajuima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α.
Article CAS Google Scholar Minnich A, Tian N, Byan L, Bilder G: A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle. CAS Google Scholar Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T: Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes.
Article CAS Google Scholar Aldridge TC, Tugwood JD, Green S: Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription.
Article CAS Google Scholar Yu S, Cao WQ, Kashireddy P, Meyer K, Jia Y, Hughes DE, Tan Y, Feng J, Yeldandi AV, Rao MS, Costa RH, Gonzalez FJ, Reddy JK: Human peroxisome proliferator-activated receptor α supports the induction of peroxisome proliferation in PPARα-deficient mouse liver.
Article CAS Google Scholar Patel DD, Knight BL, Soutar AK, Gibbons GF, Wade DP: The effect of peroxisome-proliferator-activated receptor-α on the activity of the cholesterol 7 α-hydroxylase gene. Article CAS Google Scholar Cheema SK, Agellon LB: The murine and human cholesterol 7 α-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor α.
Article CAS Google Scholar Guillou H, Martin P, Jan S, D'Andrea S, Roulet A, Catheline D, Rioux V, Pineaut T, Legrand P: Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor α-deficient mice.
Article CAS Google Scholar Wolfrum C, Ellinghaus P, Fobker M, Seedorf U, Assmann G, Borchers T, Spener F: Phytanic acid is ligand and transcriptional activator of muring liver fatty acid binding protein.
CAS Google Scholar Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner.
Article CAS Google Scholar Yamazaki K, Kuromitsu J, Tanaka I: Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor α agonists.
Article CAS Google Scholar Kok T, Wolters H, Bloks W, Havinga R, Jansen PL, Staels B, Kuipers F: Induction of hepatic ABC transporter expression is part of the PPARα-mediated fasting response in the mouse.
Article CAS Google Scholar Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI: Cross talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α.
CAS Google Scholar Hsu MH, Savas U, Griffin KJ, Johnson EF: Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor α in HepG2 cells. Article CAS Google Scholar Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM: Peroxisome proliferator-activated receptor a-mediated pathways are altered in hepatocyte-specific retinoid X receptor a-deficient mice.
CAS Google Scholar Hegardt FG: Transcriptional regulation of mitochondrial HMG-CoA synthase in the control of ketogenesis. Article CAS Google Scholar Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall AR, Fruchart JC, Staels B, Lagrost L, Luc G: Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
Article CAS Google Scholar Miller CW, Ntambi JM: Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. How do microbial lipids alter intestinal and circulating lipid concentrations, and thereby impact metabolic regulation of the host?
All submissions should be made by June 30th, Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis Non-high-density lipoprotein cholesterol non-HDL-C may be an independent risk factor for cardio-cerebrovascular disease CVD ; however, the cutoff level in patients on maintenance hemodialysis MHD is unknown.
Authors: Denggui Luo, Yueming Luo, Yanhong Zou, Yuanzhao Xu, Bo Fu, Dong Yang, Jun Yang, Cai Xu, Shuyi Ling, Shunmin Li and Airong Qi. Citation: Lipids in Health and Disease 20 Content type: Research Published on: 13 November Authors: Dan-meng Zheng, Zhen-ni An, Ming-hao Ge, Dong-zhuo Wei, Ding-wen Jiang, Xue-jiao Xing, Xiao-lei Shen and Chang Liu.
Content type: Research Published on: 2 November Authors: Stephanie M. Wilson, Adam P. Maes, Carl J. Yeoman, Seth T. Walk and Mary P. Content type: Research Published on: 20 September Authors: Szu-Wei Huang, Yu-Che Ou, Kuo-Shu Tang, Hong-Ren Yu, Li-Tung Huang, You-Lin Tain, I-Chun Lin, Jiunn-Ming Sheen, Chih-Yao Hou, Ching-Chou Tsai and Mao-Meng Tiao.
Gill, S. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab 13, — Gillon, A. Vesicle-mediated ER export of proteins and lipids. Biochim Biophys Acta Mol Cell Biol Lipids , — Girard, J.
Goldberg, A. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients.
J Clin Lipidol 5, — Goldstein, J. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.
Regulation of the mevalonate pathway. The LDL receptor. Arterioscler Thromb Vasc Biol 29, — A century of cholesterol and coronaries: from plaques to genes to statins.
Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1, 1— Protein sensors for membrane sterols.
Cell , 35— Gong, J. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. Gong, X. Structural insights into the Niemann-Pick C1 NPC1 -mediated cholesterol transfer and Ebola infection.
Gonzalez, E. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8, — Gonzalez, G. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine Cell 59, — Gordon, D. Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles.
Trends Cell Biol 5, — Gouni-Berthold, I. Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.
Br J Clin Pharmacol 82, — Graf, G. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. Granneman, J. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 Abhd5 and adipose triglyceride lipase Atgl. Greenberg, A.
Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. Gross, D. Direct binding of triglyceride to fat storage-inducing transmembrane proteins 1 and 2 is important for lipid droplet formation. Grundy, S.
J Am Coll Cardiol 73, e—e Gu, Q. Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting. Hepatology 60, — Guo, Y. Functional genomic screen reveals genes involved in lipid-droplet formation and utilization.
Gürkan, C. The COPII cage: unifying principles of vesicle coat assembly. Nat Rev Mol Cell Biol 7, — Haemmerle, G. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC Nat Med 17, — Halestrap, A.
The SLC16 gene family—Structure, role and regulation in health and disease. The monocarboxylate transporter family-Role and regulation. IUBMB Life 64, — Hall, R. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin.
Han, J. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Hardie, D. AMPK: a nutrient and energy sensor that maintains energy homeostasis.
Nat Rev Mol Cell Biol 13, — Hariri, H. Mdm1 maintains endoplasmic reticulum homeostasis by spatially regulating lipid droplet biogenesis.
Harms, M. Brown and beige fat: development, function and therapeutic potential. Nat Med 19, — Hatting, M. Insulin regulation of gluconeogenesis. Ann NY Acad Sci , 21— He, G. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP Hediger, M.
The ABCs ofmembrane transporters in health and disease SLC series : introduction. Mol Aspect Med 34, 95— Heid, I. Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.
Circ Cardiovasc Genet 1, 10— Hemmings, B. Cold Spring Harb Perspect Biol 4, a Henderson, R. The genetics and screening of familial hypercholesterolaemia. J Biomed Sci 23, Henne, W. The assembly of lipid droplets and their roles in challenged cells.
Hers, H. Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem 52, — Herzig, S. CREB regulates hepatic gluconeogenesis through the coactivator PGC Hobbs, H. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.
Hum Mutat 1, — Hoffmann, T. A large electronic-health-record-based genome-wide study of serum lipids. Nat Genet 50, — Hogan, M.
Hepatic insulin resistance following chronic activation of the CREB coactivator CRTC2. Horton, J. Molecular biology of PCSK9: its role in LDL metabolism.
Trends Biochem Sci 32, 71— PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50, S—S SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
Hossain, P. Obesity and diabetes in the developing world—a growing challenge. Hua, X. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein.
Cell 87, — Huang, S. The GLUT4 glucose transporter. Cell Metab 5, — Huang, X. Region-specific requirement for cholesterol modification of sonic hedgehog in patterning the telencephalon and spinal cord. Development , — Hubbard, B. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
Hyde, C. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet 48, — Iacobazzi, V. Citrate—new functions for an old metabolite.
Biol Chem , — Infantino, V. A key role of the mitochondrial citrate carrier SLC25A1 in TNFα- and IFNγ-triggered inflammation.
Biochim Biophys Acta Gene Regulat Mech , — Ishigami, M. Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation. Sci Rep 8, Izar, M. Phytosterols and phytosterolemia: gene-diet interactions.
Genes Nutr 6, 17— Jansson, D. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Jerome, W. Lysosomes, cholesterol and atherosclerosis. Clin Lipidol 5, — Jiang, S. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol.
Nat Commun 9, Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase. PLoS Genet 15, e Jo, Y. Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice.
eLife 8, e Johnson, M. Developmentally regulated H2Av buffering via dynamic sequestration to lipid droplets in Drosophila embryos. Jones, B. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34, 29— Joshi, A.
Lipid droplet and peroxisome biogenesis occur at the same ER subdomains. Kadereit, B. Evolutionarily conserved gene family important for fat storage.
Proc Natl Acad Sci USA , 94— Kannel, W. Factors of risk in the development of coronary heart disease—six-year follow-up experience. Ann Intern Med 55, Kathiresan, S. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.
BMC Med Genet 8, S Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40, — Kaushik, S. Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis.
Nat Cell Biol 17, — Kazda, C. Evaluation of efficacy and safety of the glucagon receptor antagonist LY in patients with type 2 diabetes: and week Phase 2 studies. Dia Care 39, — Kazierad, D.
Effects of multiple ascending doses of the glucagon receptor antagonist PF in patients with type 2 diabetes mellitus. Diabetes Obes Metab 18, — Kc, S. Vitamin C enters mitochondria via facilitative glucose transporter 1 Glut1 and confers mitochondrial protection against oxidative injury.
FASEB J 19, — Khachadurian, A. The inheritance of essential familial hypercholesterolemia. Am J Med 37, — Experiences with the homozygous cases of familial hypercholesterolemia. Ann Nutr Metab 15, — Khoriaty, R. Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo.
Proc Natl Acad Sci USA , E—E Article PubMed CAS PubMed Central Google Scholar. Kimmel, A. The Perilipins: major cytosolic lipid droplet-associated proteins and their roles in cellular lipid storage, mobilization, and systemic homeostasis.
Annu Rev Nutr 36, — Klarin, D. Koepsell, H. The SLC22 family with transporters of organic cations, anions and zwitterions.
Kolovou, G. Tangier disease four decades of research: a reflection of the importance of HDL. Curr Med Chem 13, — Koo, S. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Kooner, J. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides.
Kory, N. Targeting fat: mechanisms of protein localization to lipid droplets. Trends Cell Biol 26, — Protein crowding is a determinant of lipid droplet protein composition. Dev Cell 34, — Kotani, K.
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. Krahmer, N. Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase.
Cell Metab 14, — Kumar, N. Identification of SR ML : a synthetic RORα selective inverse agonist. ACS Chem Biol 6, — Kurland, I.
Protein Sci 4, — Kwok, R. Nuclear protein CBP is a coactivator for the transcription factor CREB. Kwon, H. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. The structure of the NPC1L1 N-Terminal domain in a closed conformation.
PLoS ONE 6, e Lagace, T. PCSK9 and LDLR degradation. Curr Opin Lipidol 25, — Lang, M. Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation.
Lange, L. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am J Hum Genet 94, — Lange, Y. Quantitation of the pool of cholesterol associated with acyl-CoA:cholesterol acyltransferase in human fibroblasts.
Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. Lass, A. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI and defective in Chanarin-Dorfman syndrome. Cell Metab 3, — Lee, J. Lee, M. Bi-directional protein transport between the ER and Golgi.
Annu Rev Cell Dev Biol 20, 87— Lee, Y. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.
Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.. Proc Natl Acad Sci USA 91, — Lengacher, S.
Resistance to diet-induced obesity and associated metabolic perturbations in haploinsufficient monocarboxylate transporter 1 mice. PLoS ONE 8, e Lewis, P.
Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Li, E. OLFR mediates glucose metabolism as a receptor of asprosin. Cell Metab 30, — Li, J. Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export.
eLife 5, e Li, P. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1.
Nat Med 20, 80— Li, T. Tipmediated lipin 1 acetylation and ER translocation determine triacylglycerol synthesis rate. Li, X. Li, Z. Drosophila lipid droplets buffer the H2Av supply to protect early embryonic development.
Curr Biol 24, — Lipid droplets control the maternal histone supply of Drosophila embryos. Curr Biol 22, — Liao, Y. The non-canonical NF-κB pathway promotes NPC2 expression and regulates intracellular cholesterol trafficking. Sci China Life Sci 61, — Lin, H.
Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 14, 9— Linton, M. SR-BI: a multifunctional receptor in cholesterol homeostasis and atherosclerosis. Trends Endocrinol Metab 28, — Lira, V. Nitric oxide and AMPK cooperatively regulate PGC-1α in skeletal muscle cells.
J Physiol , — Liscum, L. Intracellular cholesterol transport. Biochim Biophys Acta Mol Cell Biol Lipids , 19— Listenberger, L. Triglyceride accumulation protects against fatty acid-induced lipotoxicity.
Liu, B. Liu, D. Nat Genet 49, — Liu, L. Coupling of COPII vesicle trafficking to nutrient availability by the IRE1α-XBP1s axis. Proc Natl Acad Sci USA 23, Cell Metab 26, — Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration.
Liu, T. Clin Sci , — Liu, Y. Lizcano, J. The insulin signalling pathway. Curr Biol 12, R—R Lu, K. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively.
Am J Hum Genets 69, — Article Google Scholar. Lu, M. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 18, — Lu, X. Genetic susceptibility to lipid levels and lipid change over time and risk of incident hyperlipidemia in Chinese populations.
Circ Cardiovasc Genet 9, 37— Coding-sequence variants are associated with blood lipid levels in 14, Chinese. Hum Mol Genet 25, — Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease.
Luo, H. AIDA selectively mediates downregulation of fat synthesis enzymes by ERAD to retard intestinal fat absorption and prevent obesity.
Madiraju, A. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Magré, J. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q Nat Genet 28, — Malhotra, V.
Procollagen export from the endoplasmic reticulum. Biochm Soc Trans 43, — Mancias, J. The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope.
Mol Cell 26, — Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. EMBO J 27, — Martinez-Botas, J. Nat Genet 26, — Matsumoto, M.
Thank you metabokism visiting nature. Fat metabolism regulation are using a browser version with reguation support for CSS. To obtain the reguation experience, Metaabolism recommend you use a more meatbolism to date browser regulqtion Fat metabolism regulation off compatibility regulagion in Internet Tips for athlete nutrition. In the meantime, to ensure continued support, we are Ac in gestational diabetes the site without styles and JavaScript. Lipids entering the gastrointestinal tract include dietary lipids triacylglycerols, cholesteryl esters and phospholipids and endogenous lipids from bile phospholipids and cholesterol and from shed intestinal epithelial cells enterocytes. Here, we comprehensively review the digestion, uptake and intracellular re-synthesis of intestinal lipids as well as their packaging into pre-chylomicrons in the endoplasmic reticulum, their modification in the Golgi apparatus and the exocytosis of the chylomicrons into the lamina propria and subsequently to lymph. We also discuss other fates of intestinal lipids, including intestinal HDL and VLDL secretion, cytosolic lipid droplets and fatty acid oxidation.
0 thoughts on “Fat metabolism regulation”